Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

Very Unusual Sellar/Suprasellar Region Masses: A Review.

Abushamat LA, Kerr JM, Lopes MBS, Kleinschmidt-DeMasters BK.

J Neuropathol Exp Neurol. 2019 May 20. pii: nlz044. doi: 10.1093/jnen/nlz044. [Epub ahead of print]

PMID:
31233145
2.

ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.

Lucas CG, Gilani A, Solomon DA, Liang X, Maher OM, Chamyan G, Kleinschmidt-Demasters BK, Perry A.

Acta Neuropathol. 2019 May 22. doi: 10.1007/s00401-019-02027-7. [Epub ahead of print] No abstract available.

PMID:
31119374
3.

Neuropathological Findings in a Case of IFIH1-Related Aicardi-Goutières Syndrome.

Gilani A, Adang LA, Vanderver A, Collins A, Kleinschmidt-DeMasters BK.

Pediatr Dev Pathol. 2019 Apr 5:1093526619837797. doi: 10.1177/1093526619837797. [Epub ahead of print]

PMID:
30952201
4.

A Review of Neuropathological Features of Familial and Adult Hemophagocytic Lymphohistiocytosis.

Klein C, Kleinschmidt-DeMasters BK, Liang X, Stence N, Tuder RM, Moore BE.

J Neuropathol Exp Neurol. 2019 Mar 1;78(3):197-208. doi: 10.1093/jnen/nlz001.

PMID:
30726926
5.

Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expression.

Ormond DR, Kleinschmidt-DeMasters BK, Cavalcante D, Smith EE, Cramer SD, Lucia MS.

J Neurooncol. 2019 Apr;142(2):319-325. doi: 10.1007/s11060-019-03099-x. Epub 2019 Jan 17.

PMID:
30656528
6.

Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma.

Parker JJ, Canoll P, Niswander L, Kleinschmidt-DeMasters BK, Foshay K, Waziri A.

Sci Rep. 2018 Dec 20;8(1):18002. doi: 10.1038/s41598-018-36280-9.

7.

Clinicopathologic features of anaplastic myxopapillary ependymomas.

Lee JC, Sharifai N, Dahiya S, Kleinschmidt-DeMasters BK, Rosenblum MK, Reis GF, Samuel D, Siongco AM, Santi M, Storm PB, Ferris SP, Bollen AW, Pekmezci M, Solomon DA, Tihan T, Perry A.

Brain Pathol. 2019 Jan;29(1):75-84. doi: 10.1111/bpa.12673.

PMID:
30417460
8.

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M.

Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26. No abstract available.

PMID:
30259105
9.

The genetic landscape of ganglioglioma.

Pekmezci M, Villanueva-Meyer JE, Goode B, Van Ziffle J, Onodera C, Grenert JP, Bastian BC, Chamyan G, Maher OM, Khatib Z, Kleinschmidt-DeMasters BK, Samuel D, Mueller S, Banerjee A, Clarke JL, Cooney T, Torkildson J, Gupta N, Theodosopoulos P, Chang EF, Berger M, Bollen AW, Perry A, Tihan T, Solomon DA.

Acta Neuropathol Commun. 2018 Jun 7;6(1):47. doi: 10.1186/s40478-018-0551-z.

10.

A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.

Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, Louis DN, Yong WH, Lopes MB, Rosenblum MK, Butowski N, Tihan T, Bollen AW, Phillips JJ, Wiita AP, Yeh I, Jacobson MP, Bastian BC, Perry A, Solomon DA.

Nat Commun. 2018 Feb 23;9(1):810. doi: 10.1038/s41467-018-02826-8.

11.

Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway.

Pekmezci M, Stevers M, Phillips JJ, Van Ziffle J, Bastian BC, Tsankova NM, Kleinschmidt-DeMasters BK, Rosenblum MK, Tihan T, Perry A, Solomon DA.

Acta Neuropathol. 2018 Mar;135(3):485-488. doi: 10.1007/s00401-018-1820-4. Epub 2018 Feb 10. No abstract available.

12.

H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.

Kleinschmidt-DeMasters BK, Mulcahy Levy JM.

Clin Neuropathol. 2018 Mar/Apr;37 (2018)(2):53-63. doi: 10.5414/NP301085.

13.

PRES: Review of Histological Features.

Willard N, Honce JM, Kleinschmidt-DeMasters BK.

J Neuropathol Exp Neurol. 2018 Feb 1;77(2):100-118. doi: 10.1093/jnen/nlx112. Review.

PMID:
29325172
14.

Intracranial Ewing sarcoma: four pediatric examples.

Yang MJ, Whelan R, Madden J, Mulcahy Levy JM, Kleinschmidt-DeMasters BK, Hankinson TC, Foreman NK, Handler MH.

Childs Nerv Syst. 2018 Mar;34(3):441-448. doi: 10.1007/s00381-017-3684-7. Epub 2017 Dec 28.

15.

Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.

Carr SB, Kleinschmidt-DeMasters BK, Kerr JM, Kiseljak-Vassiliades K, Wierman ME, Lillehei KO.

J Neurosurg. 2018 Nov 1;129(5):1260-1267. doi: 10.3171/2017.5.JNS162901.

PMID:
29219752
16.

CNS Erdheim-Chester Disease: A Challenge to Diagnose.

Pan Z, Kleinschmidt-DeMasters BK.

J Neuropathol Exp Neurol. 2017 Dec 1;76(12):986-996. doi: 10.1093/jnen/nlx095. Review.

PMID:
29096034
17.

Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.

Lopez GY, Oberheim Bush NA, Phillips JJ, Bouffard JP, Moshel YA, Jaeckle K, Kleinschmidt-DeMasters BK, Rosenblum MK, Perry A, Solomon DA.

Acta Neuropathol. 2017 Dec;134(6):961-963. doi: 10.1007/s00401-017-1780-0. Epub 2017 Oct 23. No abstract available.

18.

Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.

Korshunov A, Chavez L, Sharma T, Ryzhova M, Schrimpf D, Stichel D, Capper D, Sturm D, Kool M, Habel A, Kleinschmidt-DeMasters BK, Rosenblum M, Absalyamova O, Golanov A, Lichter P, Pfister SM, Jones DTW, Perry A, von Deimling A.

Brain Pathol. 2018 Sep;28(5):656-662. doi: 10.1111/bpa.12566. Epub 2017 Oct 30.

PMID:
28990704
19.

Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.

Donson AM, Apps J, Griesinger AM, Amani V, Witt DA, Anderson RCE, Niazi TN, Grant G, Souweidane M, Johnston JM, Jackson EM, Kleinschmidt-DeMasters BK, Handler MH, Tan AC, Gore L, Virasami A, Gonzalez-Meljem JM, Jacques TS, Martinez-Barbera JP, Foreman NK, Hankinson TC; Advancing Treatment for Pediatric Craniopharyngioma Consortium.

J Neuropathol Exp Neurol. 2017 Sep 1;76(9):779-788. doi: 10.1093/jnen/nlx061.

20.

Multinodular and Vacuolating Neuronal Tumor of the Cerebrum: A New "Leave Me Alone" Lesion with a Characteristic Imaging Pattern.

Nunes RH, Hsu CC, da Rocha AJ, do Amaral LLF, Godoy LFS, Watkins TW, Marussi VH, Warmuth-Metz M, Alves HC, Goncalves FG, Kleinschmidt-DeMasters BK, Osborn AG.

AJNR Am J Neuroradiol. 2017 Oct;38(10):1899-1904. doi: 10.3174/ajnr.A5281. Epub 2017 Jul 13.

21.

p16 Loss and E2F/cell cycle deregulation in infant posterior fossa ependymoma.

Lummus SC, Donson AM, Gowan K, Jones KL, Vibhakar R, Foreman NK, Kleinschmidt-DeMasters BK.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26656. Epub 2017 May 26.

22.

Chordoma Occurs in Young Children With Tuberous Sclerosis.

Dahl NA, Luebbert T, Loi M, Neuberger I, Handler MH, Kleinschmidt-DeMasters BK, Mulcahy Levy JM.

J Neuropathol Exp Neurol. 2017 Jun 1;76(6):418-423. doi: 10.1093/jnen/nlx032.

23.

H3 K27M Mutation in Gangliogliomas can be Associated with Poor Prognosis.

Kleinschmidt-DeMasters BK, Donson A, Foreman NK, Dorris K.

Brain Pathol. 2017 Nov;27(6):846-850. doi: 10.1111/bpa.12455. Epub 2017 Apr 5. No abstract available.

PMID:
28378357
24.

Elucidating the Role of the Desmosome Protein p53 Apoptosis Effector Related to PMP-22 in Growth Hormone Tumors.

Kiseljak-Vassiliades K, Mills TS, Zhang Y, Xu M, Lillehei KO, Kleinschmidt-DeMasters BK, Wierman ME.

Endocrinology. 2017 May 1;158(5):1450-1460. doi: 10.1210/en.2016-1841.

25.

Review of xanthomatous lesions of the sella.

Kleinschmidt-DeMasters BK, Lillehei KO, Hankinson TC.

Brain Pathol. 2017 May;27(3):377-395. doi: 10.1111/bpa.12498.

PMID:
28236350
26.

Adamantinomatous craniopharyngioma and xanthomatous lesions of the sella.

Hankinson TC, Kleinschmidt-DeMasters BK.

Brain Pathol. 2017 May;27(3):356-357. doi: 10.1111/bpa.12497. No abstract available.

PMID:
28236347
27.

IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over.

Robinson C, Kleinschmidt-DeMasters BK.

J Neuropathol Exp Neurol. 2017 Feb 1;76(2):151-154. doi: 10.1093/jnen/nlw112.

PMID:
28110298
28.

Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors.

Mulcahy Levy JM, Zahedi S, Griesinger AM, Morin A, Davies KD, Aisner DL, Kleinschmidt-DeMasters BK, Fitzwalter BE, Goodall ML, Thorburn J, Amani V, Donson AM, Birks DK, Mirsky DM, Hankinson TC, Handler MH, Green AL, Vibhakar R, Foreman NK, Thorburn A.

Elife. 2017 Jan 17;6. pii: e19671. doi: 10.7554/eLife.19671.

29.

Desmoplastic infantile astrocytoma/ganglioglioma with rare BRAF V600D mutation.

Greer A, Foreman NK, Donson A, Davies KD, Kleinschmidt-DeMasters BK.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26350. Epub 2016 Nov 10.

30.

Histological features of pituitary adenomas and sellar region masses.

Kleinschmidt-DeMasters BK.

Curr Opin Endocrinol Diabetes Obes. 2016 Dec;23(6):476-484. Review.

PMID:
27763894
31.

Radiation-Induced Cerebral Vascular "Malformations" at Biopsy.

Kleinschmidt-DeMasters BK, Lillehei KO.

J Neuropathol Exp Neurol. 2016 Nov 1;75(11):1081-1092. doi: 10.1093/jnen/nlw085.

PMID:
27694117
32.

Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment.

Nyberg E, Honce J, Kleinschmidt-DeMasters BK, Shukri B, Kreidler S, Nagae L.

Neuroradiol J. 2016 Oct;29(5):377-83. doi: 10.1177/1971400916665375. Epub 2016 Aug 19.

33.

Double separate versus contiguous pituitary adenomas: MRI features and endocrinological follow up.

Roberts S, Borges MT, Lillehei KO, Kleinschmidt-DeMasters BK.

Pituitary. 2016 Oct;19(5):472-81. doi: 10.1007/s11102-016-0727-0.

PMID:
27209585
34.

Diffuse astrocytoma arising within a demyelinating plaque.

Ormond DR, Kleinschmidt-DeMasters BK.

J Neurooncol. 2016 Jun;128(2):373-5. doi: 10.1007/s11060-016-2118-9. Epub 2016 Mar 31. No abstract available.

PMID:
27033061
35.

SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups.

Kleinschmidt-DeMasters BK, Donson AM, Richmond AM, Pekmezci M, Tihan T, Foreman NK.

J Neuropathol Exp Neurol. 2016 Apr;75(4):295-8. doi: 10.1093/jnen/nlw010. Epub 2016 Mar 4.

36.

Erratum to: Clinical metagenomic identification of Balamuthia mandrillaris encephalitis and assembly of the draft genome: the continuing case for reference genome sequencing.

Greninger AL, Messacar K, Dunnebacke T, Naccache SN, Federman S, Bouquet J, Mirsky D, Nomura Y, Yagi S, Glaser C, Vollmer M, Press CA, Kleinschmidt-DeMasters BK, Dominguez SR, Chiu CY.

Genome Med. 2016 Jan 11;8(1):1. doi: 10.1186/s13073-015-0257-9. No abstract available.

37.

Clinical metagenomic identification of Balamuthia mandrillaris encephalitis and assembly of the draft genome: the continuing case for reference genome sequencing.

Greninger AL, Messacar K, Dunnebacke T, Naccache SN, Federman S, Bouquet J, Mirsky D, Nomura Y, Yagi S, Glaser C, Vollmer M, Press CA, Kleinschmidt-DeMasters BK, Dominguez SR, Chiu CY.

Genome Med. 2015 Dec 1;7:113. doi: 10.1186/s13073-015-0235-2. Erratum in: Genome Med. 2016;8(1):1. Klenschmidt-DeMasters, Bette K [corrected to Kleinschmidt-DeMasters, Bette K].

38.

Dual use of E-cadherin and D2-40 immunostaining in unusual meningioma subtypes.

Mrachek EK, Davis D, Kleinschmidt-DeMasters BK.

Am J Clin Pathol. 2015 Dec;144(6):923-34. doi: 10.1309/AJCPSULJ6DW5REHR.

PMID:
26573000
39.

CNS Masson Tumors: Frequent Association With Therapeutic Radiation.

Mann P, Kleinschmidt-DeMasters BK.

Am J Surg Pathol. 2016 Jan;40(1):81-93. doi: 10.1097/PAS.0000000000000539.

PMID:
26492183
40.

Genetics of Glioblastomas in Rare Anatomical Locations: Spinal Cord and Optic Nerve.

Shows J, Marshall C, Perry A, Kleinschmidt-DeMasters BK.

Brain Pathol. 2016 Jan;26(1):120-3. doi: 10.1111/bpa.12327. No abstract available.

PMID:
26443345
41.

Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors.

Kiseljak-Vassiliades K, Xu M, Mills TS, Smith EE, Silveira LJ, Lillehei KO, Kerr JM, Kleinschmidt-DeMasters BK, Wierman ME.

Mol Cell Endocrinol. 2015 Dec 5;417:73-83. doi: 10.1016/j.mce.2015.09.016. Epub 2015 Sep 21.

42.

Prominent Vascular and Perivascular Eosinophilic Infiltrates Heralding CNS Mycosis Fungoides.

Schowinsky J, Leppert M, Ney D, Kleinschmidt-DeMasters BK.

J Neuropathol Exp Neurol. 2015 Oct;74(10):948-51. doi: 10.1097/NEN.0000000000000245.

PMID:
26352990
43.

Massive dissemination of adult glioblastomas.

Willard N, Kleinschmidt-DeMasters BK.

Clin Neuropathol. 2015 Nov-Dec;34(6):330-42. doi: 10.5414/NP300882.

PMID:
26308254
44.

West Nile Virus Encephalitis 16 Years Later.

Kleinschmidt-DeMasters BK, Beckham JD.

Brain Pathol. 2015 Sep;25(5):625-33. doi: 10.1111/bpa.12280. Review.

PMID:
26276026
45.

Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.

Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, Kleinschmidt-DeMasters BK, Johnston JM, Anderson RC, Rosenfeld A, Handler M, Gore L, Foreman N, Hankinson TC.

Acta Neuropathol Commun. 2015 May 21;3:30. doi: 10.1186/s40478-015-0211-5.

46.

An algorithmic approach to sellar region masses.

Kleinschmidt-DeMasters BK, Lopes MB, Prayson RA.

Arch Pathol Lab Med. 2015 Mar;139(3):356-72. doi: 10.5858/arpa.2014-0020-OA.

PMID:
25724033
47.

Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia.

Xiong W, Knox AJ, Xu M, Kiseljak-Vassiliades K, Colgan SP, Brodsky KS, Kleinschmidt-Demasters BK, Lillehei KO, Wierman ME.

Mol Endocrinol. 2015 Mar;29(3):460-72. doi: 10.1210/me.2014-1332. Epub 2015 Feb 4.

48.

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.

Kleinschmidt-DeMasters BK, Aisner DL, Foreman NK.

Am J Surg Pathol. 2015 Apr;39(4):528-40. doi: 10.1097/PAS.0000000000000363.

49.

Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.

Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C.

J Neurooncol. 2015 Mar;122(1):135-43. doi: 10.1007/s11060-014-1691-z. Epub 2014 Dec 19.

PMID:
25524817
50.

Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PA.

Kleinschmidt-DeMasters BK, Donson AM, Vogel H, Foreman NK.

Brain Pathol. 2015 Jul;25(4):429-40. doi: 10.1111/bpa.12239. Epub 2015 Jan 27.

Supplemental Content

Loading ...
Support Center